Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06111508
What this trial is testing

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Who this might be right for
Type 2 Diabetes
University of Virginia 30
Early research (Phase 1)Study completedNCT01582308
What this trial is testing

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 22
Early research (Phase 1)Study completedNCT01165268
What this trial is testing

Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Large-scale testing (Phase 3)Ended earlyNCT00970424
What this trial is testing

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type II
Forest Laboratories 252
Large-scale testing (Phase 3)Ended earlyNCT04606576
What this trial is testing

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 710
Very early researchStudy completedNCT05093517
What this trial is testing

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4
Early research (Phase 1)Study completedNCT02411825
What this trial is testing

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 76
Large-scale testing (Phase 3)Study completedNCT01513369
What this trial is testing

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency

Who this might be right for
Type 2 Diabetes MellitusIron Deficiency
GWT-TUD GmbH 152
Not applicableStudy completedNCT01523405
What this trial is testing

A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM

Who this might be right for
Type II Diabetes Mellitus
AstraZeneca 4,911
Not applicableStudy completedNCT04390711
What this trial is testing

Association of Carbamylated HDL and CAD in T2DM Patients

Who this might be right for
Type 2 Diabetes Mellitus With Circulatory Complciation
RenJi Hospital 282
Large-scale testing (Phase 3)Study completedNCT03954834
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 478
Early research (Phase 1)Looking for participantsNCT07463196
What this trial is testing

A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors

Who this might be right for
Healthy ParticipantsObesityType 2 Diabetes Mellitus (T2DM)
AC Immune SA 114
Not applicableNot Yet RecruitingNCT05925946
What this trial is testing

Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM

Who this might be right for
Diabetes MellitusPreDiabetesDiet Habit
Diabetes Foundation, India 60
Large-scale testing (Phase 3)UnknownNCT06141980
What this trial is testing

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Daewoong Pharmaceutical Co. LTD. 134
Post-approval studies (Phase 4)UnknownNCT04982380
What this trial is testing

Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation

Who this might be right for
Type 2 Diabetes Mellitus With Complication
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03244800
What this trial is testing

Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 65
Not applicableNot Yet RecruitingNCT07778771
What this trial is testing

CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity

Who this might be right for
StrokeHypertensionType 2 Diabetes Mellitus (T2DM)+1 more
Duke Kunshan University 365
Early research (Phase 1)Study completedNCT01103609
What this trial is testing

Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 16
Not applicableNot Yet RecruitingNCT07191834
What this trial is testing

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Who this might be right for
Rifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid
Wuhan Pulmonary Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03604419
What this trial is testing

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 214
Next Page